Discontinued — last reported Q4 '25
Operating
Contingent Value Right, Unrealized Gain (Loss), Noncash
Over 4 years (FY 2021 to FY 2025), Contingent Value Right, Unrealized Gain (Loss), Noncash shows a downward trend with a -100.0% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryProfitability
SignalContext dependent
VolatilityVolatile
First reportedQ1 2019
Last reportedQ4 2025Feb 12, 2026
How to read this metric
An increase represents a non-cash gain from a reduction in estimated future payouts, while a decrease represents a non-cash loss from an increase in estimated future payouts.
Detailed definition
Represents the non-cash impact of changes in the fair value of contingent consideration liabilities related to past acqu...
Peer comparison
Common in life science companies with active M&A strategies; peers often report this as a line item in operating cash flow reconciliations.
Metric ID:
operating_contingent_value_right_unrealized_gain_loss_noncashHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.50M | $7.50M | $7.50M | -$1.75M | -$1.75M | -$1.75M | -$1.75M | $3.00M | $0.00 | $5.00M | $2.00M | $3.00M | $8.00M | $4.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | -123.3% | +0.0% | +0.0% | +0.0% | +271.4% | -100.0% | — | -60.0% | +50.0% | +166.7% | -50.0% | -100.0% | — | — | — | — |
| YoY Change | — | — | — | — | -123.3% | -123.3% | -123.3% | +271.4% | +100.0% | +385.7% | +214.3% | +0.0% | — | -20.0% | -100.0% | -100.0% | -100.0% | -100.0% | — |
Range-$1.75M – $8.00M
CAGR-100.0%
Avg YoY Growth+14.0%
Median YoY Growth-100.0%
Contingent Value Right, Unrealized Gain (Loss), Noncash at Other Companies
Frequently Asked Questions
- What is Illumina's contingent value right, unrealized gain (loss), noncash?
- Illumina (ILMN) reported contingent value right, unrealized gain (loss), noncash of $0.00 in Q4 2025.
- What is the long-term trend for Illumina's contingent value right, unrealized gain (loss), noncash?
- Over 4 years (2021 to 2025), Illumina's contingent value right, unrealized gain (loss), noncash has grown at a -100.0% compound annual growth rate (CAGR), from $30.00M to $0.00.
- What does contingent value right, unrealized gain (loss), noncash mean?
- Non-cash gains or losses from revaluing potential future acquisition payments.